FDA has placed partial clinical hold on LINNET study of lorigerlimab in gynecologic cancer. FDA has placed partial clinical hold on LINNET study of lorigerlimab in gynecologic cancer ... .
A blend of tara shrub extract and red seaweed compounds creates a protective film that makes hair 29% shinier, 21% easier to comb and 16% thicker ... .
The study will test whether tirzepatide, marketed as Zepbound, can reduce biological age — a measure of how well cells and organ systems function that can differ from chronological age, the number of years a person has lived ....
OperationEarlyImpact confirms kayak fishing as a powerful, research‑backed path to better stress management, confidence, and relationships for veterans, first responders, and their families ....
The study analysed responses from women participating in the COVID Symptom Study Biobank, drawn from the King's College London/ZOE COVID Symptom Study ... The study Patient-centred postpartum care provision.
A transportation planning study now underway in Oldham County will evaluate potential improvements to KY 146 (La Grange Road) between KY 329B and KY 393. The study will identify short-term and ...
) MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial. FDA has placed partial clinical hold on LINNET study of lorigerlimab in gynecologic cancer ...Current study participants may continue to receive study drug.